These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17428377)

  • 1. Part 3: Newer therapies for ANCA-associated vasculitis.
    Jayne D
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S77-9. PubMed ID: 17428377
    [No Abstract]   [Full Text] [Related]  

  • 2. New aspects in the management of ANCA-positive vasculitis.
    Levy J
    Nephrol Dial Transplant; 2001 Jul; 16(7):1314-7. PubMed ID: 11427616
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis.
    Golbin JM; Specks U
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S74-6. PubMed ID: 17428376
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic vasculitis treatment and monitoring update, 2008.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2008; 66(3):228-30. PubMed ID: 18937637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part 1: The need for novel treatment regimens for ANCA-associated vasculitis.
    Merkel PA
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S72-3. PubMed ID: 17428375
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
    Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
    [No Abstract]   [Full Text] [Related]  

  • 8. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.
    Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M
    Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
    Jayne DR; Chapel H; Adu D; Misbah S; O'Donoghue D; Scott D; Lockwood CM
    QJM; 2000 Jul; 93(7):433-9. PubMed ID: 10874052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Tervaert JW; Stegeman CA; Kallenberg CG
    Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):211-7. PubMed ID: 11224696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
    Huugen D; Tervaert JW; Heeringa P
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1100-7. PubMed ID: 17699331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancytopenia in ANCA associated vasculitis: response to immunosuppressive therapy.
    Letellier E; Cunningham J; Feakins RM; Hughes GR; D'Cruz DP
    Clin Exp Rheumatol; 2003; 21(3):415-6. PubMed ID: 12846080
    [No Abstract]   [Full Text] [Related]  

  • 15. 4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside.
    Yoshida M
    Intern Med; 2002 Jan; 41(1):47-9. PubMed ID: 11838592
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary affectation of vasculitis.
    Martín-Suñé N; Ríos-Blanco JJ
    Arch Bronconeumol; 2012 Nov; 48(11):410-8. PubMed ID: 22682604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
    Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
    Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary systemic vasculitis.
    Day C; Savage C
    Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA-positive vasculitis.
    Kamesh L; Harper L; Savage CO
    J Am Soc Nephrol; 2002 Jul; 13(7):1953-60. PubMed ID: 12089393
    [No Abstract]   [Full Text] [Related]  

  • 20. What place for the new biologics in the treatment of necrotising vasculitides.
    Jayne D
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S1-5. PubMed ID: 16859587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.